CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Mainly Alpha (13335)
(-)
Architecture: Orthogonal Bundle (10391)
(-)
Topology: Retinoid X Receptor (409)
(-)
Homologous Superfamily: Retinoid X Receptor (409)
(-)
Ascidiacea (Polyandrocarpa misakiensis) (1)
2Q60C:105-326; A:103-324; B:106-325; D:103-323CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF POLYANDROCARPA MISAKIENSIS RXR IN TETRAMER IN ABSENCE OF LIGAND
(-)
Bemisia tabaci. Organism_taxid: 7038. (1)
1Z5XU:300-492; E:179-415HEMIPTERAN ECDYSONE RECEPTOR LIGAND-BINDING DOMAIN COMPLEXED WITH PONASTERONE A
(-)
Biomphalaria glabrata. Organism_taxid: 6526. (1)
1XIUB:209-432; A:210-430CRYSTAL STRUCTURE OF THE AGONIST-BOUND LIGAND-BINDING DOMAIN OF BIOMPHALARIA GLABRATA RXR
(-)
Black rat (Rattus rattus) (1)
1M7WA:142-367; D:139-367; C:140-367; B:140-367HNF4A LIGAND BINDING DOMAIN WITH BOUND FATTY ACID
(-)
Chimpanzee (Pan troglodytes) (8)
1T73A:669-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXFF MOTIF
1T74A:670-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A WXXLF MOTIF
1T76A:670-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A WXXVW MOTIF
1T79A:669-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXLW MOTIF
1T7FA:669-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A LXXLL MOTIF
1T7MA:670-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXYF MOTIF
1T7RA:669-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXLF MOTIF
1T7TA:669-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH 5-ALPHA DIHYDROTESTOSTERONE
(-)
Drosophila melanogaster. Organism_taxid: 7227. (1)
1HG4C:238-502; D:238-502; A:238-502; B:238-502; E:238-502; F:238-502ULTRASPIRACLE LIGAND BINDING DOMAIN FROM DROSOPHILA MELANOGASTER
(-)
Florida lancelet (Branchiostoma floridae) (1)
3EYBA:266-484; B:266-484; C:266-484; D:266-484STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE LIGAND BINDING DOMAIN OF A NON-DUPLICATED RXR FROM THE INVERTEBRATE CHORDATE AMPHIOXUS
(-)
Fruit fly (Drosophila melanogaster) (2)
1PDUA:319-548; B:320-547LIGAND-BINDING DOMAIN OF DROSOPHILA ORPHAN NUCLEAR RECEPTOR DHR38
2IZ2  [entry was replaced by entry 2XHS without any CATH domain information]
(-)
Homo sapiens. (1)
3CS8A:202-476STRUCTURAL AND BIOCHEMICAL BASIS FOR THE BINDING SELECTIVITY OF PPARG TO PGC-1A
(-)
Homo sapiens. Human (1)
2QMVA:207-476HIGH RESOLUTION STRUCTURE OF PEROXISONE PROLIFERATION-ACTIVATED RECEPTOR GAMMA AND CHARACTERISATION OF ITS INTERACTION WITH THE CO-ACTIVATOR TRANSCRIPTIONAL INTERMEDIARY FACTOR 2
(-)
Homo sapiens. Organism_taxid: 9606. (1)
3D24C:192-423; A:194-420CRYSTAL STRUCTURE OF LIGAND-BINDING DOMAIN OF ESTROGEN-RELATED RECEPTOR ALPHA (ERRALPHA) IN COMPLEX WITH THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR COACTIVATOR-1ALPHA BOX3 PEPTIDE (PGC-1ALPHA)
(-)
Homo sapiens. Organism_taxid: 9606. (1)
1H9UA:299-522; B:299-522; C:299-522; D:299-522THE STRUCTURE OF THE HUMAN RETINOID-X-RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH THE SPECIFIC SYNTHETIC AGONIST LG100268
(-)
House mouse (Mus musculus) (11)
1DKFB:182-416; A:230-462CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS
1PK5B:319-559; A:318-559CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR LRH-1
1S9PD:234-458; C:234-452; B:234-450; A:233-447CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH DIETHYLSTILBESTROL
1S9QA:232-456; B:234-455CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXYTAMOXIFEN
1VJBA:234-441; B:233-442CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXYTAMOXIFEN
1XDKB:175-419; A:231-463; E:231-463; F:175-419CRYSTAL STRUCTURE OF THE RARBETA/RXRALPHA LIGAND BINDING DOMAIN HETERODIMER IN COMPLEX WITH 9-CIS RETINOIC ACID AND A FRAGMENT OF THE TRAP220 COACTIVATOR
1XNXA:114-345; B:120-357CRYSTAL STRUCTURE OF CONSTITUTIVE ANDROSTANE RECEPTOR
1YMTA:217-459MOUSE SF-1 LBD
1YP0A:223-461STRUCTURE OF THE STEROIDOGENIC FACTOR-1 LIGAND BINDING DOMAIN BOUND TO PHOSPHOLIPID AND A SHP PEPTIDE MOTIF
1ZH7A:318-560; B:318-560STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP
2QPYA:671-918AR LBD WITH SMALL MOLECULE
(-)
Human (Homo sapiens) (337)
1A28B:683-931; A:682-932HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN
1A52A:306-544; B:305-544ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL
1BSXA:211-461; B:211-461STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONS
1DB1A:120-423CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D COMPLEXED TO VITAMIN D
1E3GA:669-918HUMAN ANDROGEN RECEPTOR LIGAND BINDING IN COMPLEX WITH THE LIGAND METRIBOLONE (R1881)
1E3KB:683-931; A:682-932HUMAN PROGESTERON RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE LIGAND METRIBOLONE (R1881)
1EREA:305-548; B:305-548; C:305-548; D:305-548; E:305-548; F:305-548HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL
1ERRA:307-547; B:306-551HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE
1EXAA:182-417ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE ACTIVE R-ENANTIOMER BMS270394.
1EXXA:182-417ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE INACTIVE S-ENANTIOMER BMS270395.
1FBYA:224-458; B:1229-1458CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO 9-CIS RETINOIC ACID
1FCXA:183-417ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID BMS184394
1FCYA:182-417ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARBETA/GAMMA-SELECTIVE RETINOID CD564
1FCZA:183-417ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156
1FD0A:183-417ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID SR11254
1FM6A:227-458; U:227-458; D:206-477; X:206-477THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.
1FM9A:227-458; D:206-477THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES.
1G1UB:231-459; D:231-459; A:231-458; C:231-456THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN IN TETRAMER IN THE ABSENCE OF LIGAND
1G50C:2304-2547; B:1304-1549; A:304-550CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION
1G5YB:231-459; D:231-459; A:231-458; C:231-456THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER.
1GS4A:670-917STRUCTURAL BASIS FOR THE GLUCOCORTICOID RESPONSE IN A MUTANT HUMAN ANDROGEN RECEPTOR (ARCCR) DERIVED FROM AN ANDROGEN-INDEPENDENT PROSTATE CANCER
1GWQB:301-548; A:301-548HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE
1GWRB:305-548; A:306-549HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE
1GWXA:207-477; B:207-477MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
1I7GA:199-468CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242
1I7IA:207-476; B:207-473CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242
1IE8A:120-423CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO KH1060
1IE9A:118-423CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO MC1288
1ILGA:142-431CRYSTAL STRUCTURE OF APO HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN
1ILHA:142-431CRYSTAL STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TO SR12813
1K74A:227-458; D:206-477THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-ACTIVATOR PEPTIDES.
1K7LA:202-468; C:202-468; E:202-468; G:202-468THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE.
1KKQA:200-468; B:200-468; C:200-468; D:200-468CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF
1KNUB:207-475; A:204-476LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST
1KV6A:235-456; B:235-456X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ERR3 LIGAND-BINDING DOMAIN IN THE CONSTITUTIVELY ACTIVE CONFORMATION
1L2IA:305-547; B:305-547HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE
1L2JA:261-501; B:255-497HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R, R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL
1LBDA:225-462LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA
1LV2A:99-327HEPATOCYTE NUCLEAR FACTOR 4 IS A TRANSCRIPTION FACTOR THAT CONSTITUTIVELY BINDS FATTY ACIDS
1M13A:142-434CRYSTAL STRUCTURE OF THE HUMAN PREGANE X RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH HYPERFORIN, A CONSTITUENT OF ST. JOHN'S WORT
1M2ZD:525-777; A:523-777CRYSTAL STRUCTURE OF A DIMER COMPLEX OF THE HUMAN GLUCOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEXAMETHASONE AND A TIF2 COACTIVATOR MOTIF
1MV9A:229-460CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE EICOSANOID DHA (DOCOSA HEXAENOIC ACID) AND A COACTIVATOR PEPTIDE
1MVCA:229-458CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE
1MZNA:227-458; E:2227-2458; C:1229-1458; G:3229-3458CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE
1N46B:211-461; A:211-461CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC
1N83A:261-511CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE ORPHAN NUCLEAR HORMONE RECEPTOR ROR(ALPHA)-LBD AND CHOLESTEROL
1NAVA:146-408THYROID RECEPTOR ALPHA IN COMPLEX WITH AN AGONIST SELECTIVE FOR THYROID RECEPTOR BETA1
1NAXA:211-460THYROID RECEPTOR BETA1 IN COMPLEX WITH A BETA-SELECTIVE LIGAND
1NDEA:261-500ESTROGEN RECEPTOR BETA WITH SELECTIVE TRIAZINE MODULATOR
1NHZA:530-776CRYSTAL STRUCTURE OF THE ANTAGONIST FORM OF GLUCOCORTICOID RECEPTOR
1NQ0A:199-461TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD
1NQ1A:199-461TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD
1NQ2A:198-460TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING
1NRLB:142-431; A:142-433CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND SR12813
1NUOA:201-460TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING
1NYXB:207-476; A:202-476LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST
1OSHA:245-475A CHEMICAL, GENETIC, AND STRUCTURAL ANALYSIS OF THE NUCLEAR BILE ACID RECEPTOR FXR
1OVLB:363-598; E:334-598; D:363-598; A:363-598; C:363-598; F:363-598CRYSTAL STRUCTURE OF NURR1 LBD
1P8DB:218-459; A:218-461X-RAY CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN WITH 24(S),25-EPOXYCHOLESTEROL
1P93B:529-776; A:527-776; C:527-776; D:527-776CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR
1PCGB:304-547; A:304-547HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OF STEROID RECEPTOR-COACTIVATOR INTERACTIONS
1PQ6B:220-460; A:220-460; D:220-460; C:220-438HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX
1PQ9B:219-458; A:220-458; C:220-458; D:220-458HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX
1PQCB:219-458; A:220-458; C:220-458; D:220-458HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317
1PRGA:207-476; B:207-476LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA
1PZLA:137-369CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR SRC-1 PEPTIDE
1Q4XA:209-461CRYSTAL STRUCTURE OF HUMAN THYROID HORMONE RECEPTOR BETA LBD IN COMPLEX WITH SPECIFIC AGONIST GC-24
1QKMA:260-500HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN
1QKTA:304-551MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL
1QKUB:304-550; C:304-550; A:301-550WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL
1R5KA:306-545; B:306-544; C:306-544HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH GW5638
1R6GA:203-460CRYSTAL STRUCTURE OF THE THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BETA SELECTIVE COMPOUND
1RDTA:228-456; D:206-477CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER
1S0XA:261-511CRYSTAL STRUCTURE OF THE HUMAN RORALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH CHOLESTEROL SULFATE AT 2.2A
1S0ZA:120-423CRYSTAL STRUCTURE OF THE VDR LBD COMPLEXED TO SEOCALCITOL.
1S19A:120-423CRYSTAL STRUCTURE OF VDR LIGAND BINDING DOMAIN COMPLEXED TO CALCIPOTRIOL.
1SJ0A:307-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE ANTAGONIST LIGAND 4-D
1SKXA:143-431STRUCTURAL DISORDER IN THE COMPLEX OF HUMAN PXR AND THE MACROLIDE ANTIBIOTIC RIFAMPICIN
1SQNA:682-932; B:683-933PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN WITH BOUND NORETHINDRONE
1SR7A:682-932; B:683-931PROGESTERONE RECEPTOR HORMONE BINDING DOMAIN WITH BOUND MOMETASONE FUROATE
1T5ZA:669-918CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN (LBD) WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR ARA70
1T63A:669-918ACRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX3
1T65A:669-919CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FORM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX 2 BOUND IN A NON-HELICAL CONFORMATION
1TFCA:233-458; B:233-457CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE
1TXIA:120-423CRYSTAL STRUCTURE OF THE VDR LIGAND BINDING DOMAIN COMPLEXED TO TX522
1U3QB:261-497; A:263-497; C:263-497; D:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272
1U3RA:263-500; B:263-501CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-338
1U3SA:263-497; B:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-797
1U9EB:263-501; A:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397
1UHLA:298-528; B:206-445CRYSTAL STRUCTURE OF THE LXRALFA-RXRBETA LBD HETERODIMER
1UOMA:307-547THE STRUCTURE OF ESTROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE AND POTENT TETRAHYDROISOCHIOLIN LIGAND.
1UPVA:219-461CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST
1UPWA:219-461CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST
1WM0X:200-477PPARGAMMA IN COMPLEX WITH A 2-BABA COMPOUND
1X76A:263-497; B:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697
1X78A:263-500; B:263-500CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244
1X7BA:263-500; B:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041
1X7EA:305-549; B:305-549CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244
1X7JA:263-497; B:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN
1X7RA:306-547CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN
1XAPA:175-409STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOIC ACID RECEPTOR BETA
1XB7A:282-516X-RAY STRUCTURE OF ERRALPHA LBD IN COMPLEX WITH A PGC-1ALPHA PEPTIDE AT 2.5A RESOLUTION
1XJ7A:663-918COMPLEX ANDROGEN RECEPTOR LBD AND RAC3 PEPTIDE
1XLSA:227-458; B:227-458; C:227-458; D:227-458; E:117-358; F:117-358; G:117-358; H:117-358CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS
1XOWA:671-919CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH AN ANDROGEN RECEPTOR NH2-TERMINAL PEPTIDE, AR20-30, AND R1881
1XP1A:307-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15
1XP6A:307-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16
1XP9A:307-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18
1XPCA:307-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19
1XQ3A:671-919CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH R1881
1XQCA:307-548; C:307-548; B:307-548; D:307-548X-RAY STRUCTURE OF ERALPHA LBD BOUND TO A TETRAHYDROISOQUINOLINE SERM LIGAND AT 2.05A RESOLUTION
1XV9A:227-458; C:227-458; B:103-348; D:103-348CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE.
1XVPC:227-462; A:227-458; B:103-348; D:103-348CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO
1XZXX:200-460THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS
1Y0SB:209-476; A:206-475CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331
1Y0XX:199-460THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS
1Y9RA:737-983; B:737-984CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEOXYCORTICOSTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION
1YA3A:737-982; C:737-982; B:738-982CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO PROGESTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION
1YIMA:307-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 4
1YINA:307-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 3F
1YOKA:300-538CRYSTAL STRUCTURE OF HUMAN LRH-1 BOUND WITH TIF-2 PEPTIDE AND PHOSPHATIDYLGLYCEROL
1YOWA:221-458HUMAN STEROIDOGENIC FACTOR 1 LBD WITH BOUND CO-FACTOR PEPTIDE
1YUCA:299-538; B:300-539HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO PHOSPHOLIPID AND A FRAGMENT OF HUMAN SHP
1YY4A:263-497; B:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 1-CHLORO-6-(4-HYDROXY-PHENYL)-NAPHTHALEN-2-OL
1YYEA:263-500; B:263-496CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-202196
1Z95A:672-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN W741L MUTANT COMPLEX WITH R-BICALUTAMIDE
1ZAFA:263-500; B:263-500CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 3-BROMO-6-HYDROXY-2-(4-HYDROXY-PHENYL)-INDEN-1-ONE
1ZDTB:221-459; A:221-460THE CRYSTAL STRUCTURE OF HUMAN STEROIDOGENIC FACTOR-1
1ZDUA:253-492THE CRYSTAL STRUCTURE OF HUMAN LIVER RECEPTOR HOMOLOGUE-1
1ZEOB:207-475; A:207-477CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH AN ALPHA-ARYLOXYPHENYLACETIC ACID AGONIST
1ZGYA:206-477STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP
1ZKYA:304-549; B:305-549HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-3M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE
1ZUCA:682-932; B:682-932PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE NONSTEROIDAL AGONIST TANAPROGET
2A3IA:732-984STRUCTURAL AND BIOCHEMICAL MECHANISMS FOR THE SPECIFICITY OF HORMONE BINDING AND COACTIVATOR ASSEMBLY BY MINERALOCORTICOID RECEPTOR
2AA2A:727-983MINERALOCORTICOID RECEPTOR WITH BOUND ALDOSTERONE
2AA5A:722-982; B:723-982MINERALOCORTICOID RECEPTOR WITH BOUND PROGESTERONE
2AA6B:722-982; A:722-982MINERALOCORTICOID RECEPTOR S810L MUTANT WITH BOUND PROGESTERONE
2AA7A:727-983MINERALOCORTICOID RECEPTOR WITH BOUND DEOXYCORTICOSTERONE
2AAXB:723-982; A:722-983MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND CORTISONE
2AB2A:723-982; B:723-982MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND SPIRONOLACTONE
2ABIB:737-982; C:737-982; A:737-982CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEOXYCORTICOSTERONE
2ACLC:225-458; A:225-457; E:225-457; G:225-457; B:202-443; D:202-443; F:202-443; H:202-445LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987
2AM9A:670-919CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH TESTOSTERONE
2AMAA:671-919CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH DIHYDROTESTOSTERONE
2AMBA:671-919CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH TETRAHYDROGESTRINONE
2AO6A:671-918CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TIF2(III) 740-753 PEPTIDE AND R1881
2ATHA:207-477; B:207-477CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IM COMPLEX WITH AN AGONIST
2AWHB:210-476; A:210-477HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1
2AX6A:671-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH HYDROXYFLUTAMIDE
2AX7A:672-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH S-1
2AX8A:672-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN W741L MUTANT IN COMPLEX WITH S-1
2AX9A:672-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH R-3
2AXAA:672-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH S-1
2AYRA:306-551A SERM DESIGNED FOR THE TREATMENT OF UTERINE LEIOMYOMA WITH UNIQUE TISSUE SPECIFICITY FOR UTERUS AND OVARIES IN RATS
2B1VB:305-549; A:305-548HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE
2B1ZB:305-547; A:305-548HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17METHYL-17ALPHA-DIHYDROEQUILENIN AND A GLUCOC INTERACTING PROTEIN 1 NR BOX II PEPTIDE
2B23B:305-547; A:305-548HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN AND A GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1 NR BOX II PEPTIDE
2B50A:211-476; B:205-475HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2
2BAWB:211-477; A:211-475HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1
2BJ4A:305-528; B:304-529ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST
2E2RA:232-459CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH BISPHENOL A
2EWPA:233-456; B:233-456; C:234-456; D:235-455; E:237-455CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR-3 (ERR-GAMMA) LIGAND BINDING DOMAIND WITH TAMOXIFEN ANALOG GSK5182
2F4BA:207-477; B:207-477CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH AN AGONIST
2FAIB:304-548; A:305-548HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-2M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE
2FSZB:260-501; A:264-501A SECOND BINDING SITE FOR HYDROXYTAMOXIFEN WITHIN THE COACTIVATOR-BINDING GROOVE OF ESTROGEN RECEPTOR BETA
2FVJA:207-477A NOVEL ANTI-ADIPOGENIC PARTIAL AGONIST OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA (PPARG) RECRUITS PPARG-COACTIVATOR-1 ALPHA (PGC1A) BUT POTENTIATES INSULIN SIGNALING IN VITRO
2G0GA:207-477; B:207-477STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES
2G0HA:207-477; B:207-477STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES
2G44A:305-548; B:306-552HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M-G AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE
2G5OB:304-550; A:304-548HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 2-(BUT-1-ENYL)-17BETA-ESTRADIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE
2GIUA:260-500HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 45
2GL8D:11-228; C:11-227; B:11-226; A:11-224HUMAN RETINOIC ACID RECEPTOR RXR-GAMMA LIGAND-BINDING DOMAIN
2GP7B:234-458; A:235-458; C:235-458; D:235-458ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN
2GPOA:235-458ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A SYNTHETIC PEPTIDE FROM RIP140
2GPPA:233-457; B:233-456ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A RIP140 PEPTIDE AND SYNTHETIC LIGAND GSK4716
2GPUA:234-455ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN
2GPVA:232-455; B:233-455; C:233-455; D:233-441; E:234-441; F:233-440ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN AND A SMRT PEPTIDE
2GTKA:207-477STRUCTURE-BASED DESIGN OF INDOLE PROPIONIC ACIDS AS NOVEL PPARAG CO-AGONISTS
2GWXA:211-476; B:211-477MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
2H77A:152-406CRYSTAL STRUCTURE OF HUMAN TR ALPHA BOUND T3 IN MONOCLINIC SPACE GROUP
2H79A:142-408CRYSTAL STRUCTURE OF HUMAN TR ALPHA BOUND T3 IN ORTHORHOMBIC SPACE GROUP
2HAMA:119-423CRYSTAL STRUCTURE OF VDR LBD COMPLEXED TO 2ALPHA-PROPYL-CALCITRIOL
2HARA:119-423CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2 ALPHA-(3-HYDROXY-1-PROPOXY) CALCITRIOL
2HASA:119-423CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA-(1-PROPOXY) CALCITRIOL
2HB7A:119-423CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA(3-HYDROXY-1-PROPYL) CALCITRIOL
2HB8A:119-423CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA-METHYL CALCITRIOL
2HFPA:206-477CRYSTAL STRUCTURE OF PPAR GAMMA WITH N-SULFONYL-2-INDOLE CARBOXAMIDE LIGANDS
2HVCA:669-918THE CRYSTAL STRUCTURE OF LIGAND-BINDING DOMAIN (LBD) OF HUMAN ANDROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE MODULATOR LGD2226
2HWQB:207-467; A:207-477STRUCTURAL BASIS FOR THE STRUCTURE-ACTIVITY RELATIONSHIPS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS
2HWRB:207-467; A:207-477STRUCTURAL BASIS FOR THE STRUCTURE-ACTIVITY RELATIONSHIPS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS
2I0GB:260-498; A:261-498BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA
2I0JB:306-547; D:306-547; C:306-528; A:306-528BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA
2I4JA:207-476; B:207-476CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE AGONIST LT160 (UREIDOFIBRATE DERIVATIVE)
2I4PA:207-476; B:207-476CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE PARTIAL AGONIST LT127 (UREIDOFIBRATE DERIVATIVE). STRUCTURE OBTAINED FROM CRYSTALS OF THE APO-FORM SOAKED FOR 30 DAYS.
2I4ZA:207-476; B:207-476CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE PARTIAL AGONIST LT127 (UREIDOFIBRATE DERIVATIVE). THIS STRUCTURE HAS BEEN OBTAINED FROM CRYSTALS SOAKED FOR 6 HOURS.
2IOGA:309-551HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 11F
2IOKB:1306-1544; A:306-544HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 1D
2J14B:175-439; A:174-4403,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2
2J4AA:211-461HUMAN THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH KB131084
2JF9A:305-528; C:305-529; B:305-529ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST
2JFAA:305-529; B:306-528ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE
2JJ3B:260-501; A:261-499ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST
2LBDA:182-419LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID
2NPAC:199-468; A:199-467THE CRYSTAL STRUCTURE OF THE HUMAN PPARAPLPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A A-HYDROXYIMINO PHENYLPROPANOIC ACID
2NV7A:263-500; B:263-497CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-555
2O9IA:142-433; B:1142-1433CRYSTAL STRUCTURE OF THE HUMAN PREGNANE X RECEPTOR LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND T0901317
2OAXF:738-982; D:738-982; E:738-982; A:738-982; B:739-982; C:738-982CRYSTAL STRUCTURE OF THE S810L MUTANT MINERALOCORTICOID RECEPTOR ASSOCIATED WITH SC9420
2OCFA:305-548HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH ESTRADIOL AND THE E2#23 FN3 MONOBODY
2OM9B:207-476; D:207-476; A:207-476; C:207-476AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA
2OUZA:306-551CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA-LASOFOXIFENE COMPLEX
2OVHA:681-932PROGESTERONE RECEPTOR WITH BOUND ASOPRISNIL AND A PEPTIDE FROM THE CO-REPRESSOR SMRT
2OVMA:682-932PROGESTERONE RECEPTOR WITH BOUND ASOPRISNIL AND A PEPTIDE FROM THE CO-REPRESSOR NCOR
2OZ7A:671-919CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR T877A MUTANT LIGAND-BINDING DOMAIN WITH CYPROTERONE ACETATE
2P15A:305-549; B:306-550CRYSTAL STRUCTURE OF THE ER ALPHA LIGAND BINDING DOMAIN WITH THE AGONIST ORTHO-TRIFLUOROMETHYLPHENYLVINYL ESTRADIOL
2P1TA:229-458CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-METHOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2
2P1UA:229-458CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-ETHOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2
2P1VA:229-458CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-PROPOXY)-TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2
2P4YA:205-477; B:209-477CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA-LIGAND BINDING DOMAIN COMPLEXED WITH AN INDOLE-BASED MODULATOR
2P54A:202-468A CRYSTAL STRUCTURE OF PPAR ALPHA BOUND WITH SRC1 PEPTIDE AND GW735
2P7AA:234-456CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH 3-METHYL PHENOL
2P7GA:235-456X-RAY STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH BISPHENOL A.
2P7ZA:235-441ESTROGEN RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXY-TAMOXIFEN
2PINA:210-460; B:211-460THYROID RECEPTOR BETA IN COMPLEX WITH INHIBITOR
2PIOA:671-918ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE
2PIPL:670-918ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE
2PIQA:670-918ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE
2PIRA:669-918ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE
2PITA:669-918ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE
2PIUA:671-918ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE
2PIVA:670-918ANDROGEN RECEPTOR WITH SMALL MOLECULE
2PIWA:671-918ANDROGEN RECEPTOR WITH SMALL MOLECULE
2PIXA:671-918AR LBD WITH SMALL MOLECULE
2PJLA:282-517; B:282-517CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR ALPHA IN COMPLEX WITH A SYNTHETIC INVERSE AGONIST REVEALS ITS NOVEL MOLECULAR MECHANISM
2PKLA:670-918ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE
2PNUA:670-919CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH EM-5744
2POBB:206-474; A:207-475PPARGAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A FARGLITAZAR ANALOGUE GW4709
2POGA:306-550; B:306-528BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR B AGONISTS (SERBAS). PART 2: STRUCTURE ACTIVITY RELATIONSHIP STUDIES ON THE BENZOPYRAN SCAFFOLD.
2PRGB:207-477; A:207-477LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA
2Q59B:207-475; A:207-475CRYSTAL STRUCTURE OF PPARGAMMA LBD BOUND TO FULL AGONIST MRL20
2Q5GB:209-459; A:210-474LIGAND BINDING DOMAIN OF PPAR DELTA RECEPTOR IN COMPLEX WITH A PARTIAL AGONIST
2Q5PB:207-475; A:207-476CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST MRL24
2Q5SA:208-477; B:207-476CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST NTZDPA
2Q61A:209-477; B:207-476CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN BOUND TO PARTIAL AGONIST SR145
2Q6JA:306-549; B:305-548CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED TO A B-N SUBSTITUTED LIGAND
2Q6RA:207-476; B:207-477CRYSTAL STRUCTURE OF PPAR GAMMA COMPLEXED WITH PARTIAL AGONIST SF147
2Q6SB:207-475; A:207-4742.4 ANGSTROM CRYSTAL STRUCTURE OF PPAR GAMMA COMPLEXED TO BVT.13 WITHOUT CO-ACTIVATOR PEPTIDES
2Q70A:306-549; B:306-528ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLXED TO A BENZOPYRAN LIGAND
2Q7IA:671-919THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE
2Q7JA:671-919THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX 3 COACTIVATOR PEPTIDE 740-753
2Q7KA:671-919THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE
2Q7LA:671-919THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX3 COACTIVATOR PEPTIDE 740-753
2Q8SA:207-474; B:207-475X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA IN A COMPLEX WITH A PPAR GAMMA/ALPHA DUAL AGONIST
2QA6B:306-550; A:305-549CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA MUTANT 537S COMPLEXED WITH 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL
2QA8B:305-549; A:305-548CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH GENISTEIN
2QABA:305-548; B:305-549CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH AN ETHYL INDAZOLE COMPOUND
2QE4A:306-528; B:306-528ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST
2QGTB:305-548; A:305-548CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO AN ETHER ESTRADIOL COMPOUND
2QGWA:305-548; B:305-549CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH A CHLORO-INDAZOLE COMPOUND
2QH6A:304-548; B:305-547CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DIARYLETHYLENE COMPOUND
2QNVA:142-434CRYSTAL STRUCTURE OF THE PREGNANE X RECEPTOR BOUND TO COLUPULONE
2QR9A:305-549; B:306-550CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DERIVATIVE COMPOUND
2QSEA:305-549; B:306-550CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH BURNED MEAT COMPOUND 4-OH-PHIP
2QTUB:260-500; A:261-498ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND
2QW4A:32-264; B:32-264; C:30-264; D:32-265HUMAN NR4A1 LIGAND-BINDING DOMAIN
2QXMB:306-550; A:305-549CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO BURNED MEAT COMPOUND PHIP
2QXSA:306-547; B:306-548CRYSTAL STRUCTURE OF ANTAGONIZING MUTANT 536S OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO RALOXIFENE
2QZOB:306-549; A:305-549CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH WAY-169916
2R6WA:306-549; B:306-546ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO A SERM
2R6YA:306-549; B:306-545ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SERM
2REWA:199-467CRYSTAL STRUCTURE OF PPARALPHA LIGAND BINDING DOMAIN WITH BMS-631707
2VSRB:207-474; A:207-475HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 9-(S)-HODE
2VSTB:207-474; A:204-475HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 13-(S)-HODE
2VV0B:208-476; A:203-475HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH DHA
2VV1A:206-475; B:209-473HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-HDHA
2VV2A:207-474; B:207-474HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5-HEPA
2VV3B:207-474; A:207-475HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-OXODHA
2VV4A:205-475; B:206-474HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6-OXOOTE
2W8YA:683-933; B:683-933RU486 BOUND TO THE PROGESTERONE RECEPTOR IN A DESTABILIZED AGONISTIC CONFORMATION
2Z4BB:260-500; A:261-498ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND
2Z4JA:671-918CRYSTAL STRUCTURE OF AR LBD WITH SHP PEPTIDE NR BOX 2
2ZASA:232-458CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH 4-ALPHA-CUMYLPHENOL, A BISPHENOL A DERIVATIVE
2ZBSA:232-459CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN APO FORM
2ZKCA:232-459CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH BISPHENOL Z
3B3KA:207-476; B:207-476CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE FULL AGONIST LT175
3B5RA:671-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM C-31
3B65A:671-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-24
3B66A:671-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-21
3B67A:671-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM C-23
3B68A:671-917CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM S-4
3BEJB:244-471; A:245-471STRUCTURE OF HUMAN FXR IN COMPLEX WITH MFA-1 AND CO-ACTIVATOR PEPTIDE
3BQDA:525-777DOUBLING THE SIZE OF THE GLUCOCORTICOID RECEPTOR LIGAND BINDING POCKET BY DEACYLCORTIVAZOL
3CJWA:171-407CRYSTAL STRUCTURE OF THE HUMAN COUP-TFII LIGAND BINDING DOMAIN
3CLDB:528-776; A:526-776LIGAND BINDING DOMAIN OF THE GLUCOCORTICOID RECEPTOR COMPLEXED WITH FLUTICAZONE FUROATE
3CS4A:119-423STRUCTURE-BASED DESIGN OF A SUPERAGONIST LIGAND FOR THE VITAMIN D NUCLEAR RECEPTOR
3CS6A:119-423STRUCTURE-BASED DESIGN OF A SUPERAGONIST LIGAND FOR THE VITAMIN D NUCLEAR RECEPTOR
3CWDA:208-477; B:208-476MOLECULAR RECOGNITION OF NITRO-FATTY ACIDS BY PPAR GAMMA
3D57A:210-460; B:211-460TR VARIANT D355R
3D5FA:211-476; B:211-477CRYSTAL STRUCTURE OF PPAR-DELTA COMPLEX
3D90A:682-931; B:683-932CRYSTAL STRUCTURE OF THE HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN BOUND TO LEVONORGESTREL
3DCTA:244-472FXR WITH SRC1 AND GW4064
3DCUA:244-472FXR WITH SRC1 AND GSK8062
3DT3B:306-548; A:306-551HUMAN ESTROGEN RECEPTOR ALPHA LBD WITH GW368
3DY6B:210-475; A:208-475PPARDELTA COMPLEXED WITH AN ANTHRANILIC ACID PARTIAL AGONIST
3E7CB:525-776; A:526-776GLUCOCORTICOID RECEPTOR LBD BOUND TO GSK866
3ERDB:305-550; A:305-550HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE
3ERTA:306-552HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN
3FALB:202-443; D:202-443HUMANRXR ALPHA & MOUSE LXR ALPHA COMPLEXED WITH RETENOIC ACID AND GSK2186
3FC6B:203-443; D:203-443HRXRALPHA & MLXRALPHA WITH AN INDOLE PHARMACOPHORE, SB786875
3FLIA:248-475DISCOVERY OF XL335, A HIGHLY POTENT, SELECTIVE AND ORALLY-ACTIVE AGONIST OF THE FARNESOID X RECEPTOR (FXR)
3FS1A:139-368CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR PGC-1A FRAGMENT
3FXVA:247-475IDENTIFICATION OF AN N-OXIDE PYRIDINE GW4064 ANALOGUE AS A POTENT FXR AGONIST
3G8OA:682-932; B:683-932PROGESTERONE RECEPTOR WITH BOUND PYRROLIDINE 1
3GD2A:244-472ISOXAZOLE LIGAND BOUND TO FARNESOID X RECEPTOR (FXR)
3GN8A:-2-246; B:-2-246X-RAY CRYSTAL STRUCTURE OF ANCGR2 IN COMPLEX WITH DEXAMETHASONE
3GWSX:202-460CRYSTAL STRUCTURE OF T3-BOUND THYROID HORMONE RECEPTOR
3GWXA:207-477; B:207-477MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
3H0AA:228-455CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) AND RETINOIC ACID RECEPTOR ALPHA (RXRA) IN COMPLEX WITH 9-CIS RETINOIC ACID, CO-ACTIVATOR PEPTIDE, AND A PARTIAL AGONIST
3HC5A:244-472FXR WITH SRC1 AND GSK826
3HC6A:243-472FXR WITH SRC1 AND GSK088
3HLVA:304-548; B:304-548CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND 16-ALPHA-HYDROXY-ESTRONE ((8S,9R,13S,14R, 16R)-3,16-DIHYDROXY-13-METHYL-7,8,9,11,12,14,15, 16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE
3HM1B:303-550; A:306-548CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTRONE ((8R,9S,13S,14S)-3-HYDROXY-13-METHYL-7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE)
3HZFA:145-407STRUCTURE OF TR-ALFA BOUND TO SELECTIVE THYROMIMETIC GC-1 IN C2 SPACE GROUP
3ILZA:144-410STRUCTURE OF TR-ALFA BOUND TO SELECTIVE THYROMIMETIC GC-1 IN P212121 SPACE GROUP
3IMYA:201-461STRUCTURE OF TR-BETA BOUND TO SELECTIVE THYROMIMETIC GC-1
3IPQA:205-445X-RAY STRUCTURE OF GW3965 SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA
3IPSB:205-446; A:205-446X-RAY STRUCTURE OF BENZISOXAZOLE SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA
3IPUA:204-445; B:205-445X-RAY STRUCTURE OF BENZISOXAZOLE UREA SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA
3JZBA:144-407CRYSTAL STRUCTURE OF TR-ALFA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC
3JZCA:202-460CRYSTAL STRUCTURE OF TR-BETA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC
3KFCC:220-439COMPLEX STRUCTURE OF LXR WITH AN AGONIST
3KMRA:182-415CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH AN AGONIST LIGAND (AM580) AND A COACTIVATOR FRAGMENT
3KMZA:181-401; B:181-401CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH THE INVERSE AGONIST BMS493 AND A COREPRESSOR FRAGMENT
3L1BA:245-475COMPLEX STRUCTURE OF FXR LIGAND-BINDING DOMAIN WITH A TETRAHYDROAZEPINOINDOLE COMPOUND
3LBDA:182-418LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO 9-CIS RETINOIC ACID
3PRGA:200-477LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR
4LBDA:182-418LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO THE SYNTHETIC AGONIST BMS961
4PRGA:207-476; B:207-476; C:207-476; D:207-4760072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL
(-)
Mouse (Mus musculus) (2)
3F5CA:318-560STRUCTURE OF DAX-1:LRH-1 COMPLEX
3F7DA:222-461SF-1 LBD BOUND BY PHOSPHATIDYLCHOLINE
(-)
Norway rat (Rattus norvegicus) (18)
1HJ1A:218-435RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PURE ANTIOESTROGEN ICI164,384
1I37A:672-917CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN COMPLEX WITH DIHYDROTESTOSTERONE
1I38A:672-918CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT COMPLEX WITH DIHYDROTESTOSTERONE
1K4WA:208-451X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ROR BETA LIGAND-BINDING DOMAIN IN THE ACTIVE CONFORMATION
1N4HA:1-244CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA
1NQ7A:208-451CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA
1OSVA:240-468; B:240-468STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR
1OT7A:240-468; B:240-468STRUCTURAL BASIS FOR 3-DEOXY-CDCA BINDING AND ACTIVATION OF FXR
1RJKA:123-420CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2MD AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205
1RK3A:123-420CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 1,25-DIHYDROXYVITAMIN D3 AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205
1RKGA:123-421CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2MBISP AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205
1RKHA:123-422CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2AM20R AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205
1XNNA:672-918CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT COMPLEX WITH (3A-ALPHA-,4-ALPHA 7-ALPHA-,7A-ALPHA-)-3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE.
1YJEA:362-594CRYSTAL STRUCTURE OF THE RNGFI-B LIGAND-BINDING DOMAIN
2IHQA:671-918CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMIAN COMPLEX WITH AN N-ARYL-HYDROXYBICYCLOHYDANTOIN
2NW4A:671-918CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN COMPLEX WITH BMS-564929
2O4JA:123-421CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH VITIII 17-20Z AND THE NR2 BOX OF DRIP 205
2O4RA:123-421CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH VITIII 17-20E AND THE NR2 BOX OF DRIP 205
(-)
Rat (Rattus norvegicus) (10)
1QKNA:217-452RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH ANTAGONIST RALOXIFENE
2J7XA:217-453STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5
2J7YA:217-453STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5
2ZL9A:123-4192-SUBSTITUTED-16-ENE-22-THIA-1ALPHA,25-DIHYDROXY-26,27-DIMETHYL-19-NORVITAMIN D3 ANALOGS: SYNTHESIS, BIOLOGICAL EVALUATION AND CRYSTAL STRUCTURE
2ZLAA:123-4202-SUBSTITUTED-16-ENE-22-THIA-1ALPHA,25-DIHYDROXY-26,27-DIMETHYL-19-NORVITAMIN D3 ANALOGS: SYNTHESIS, BIOLOGICAL EVALUATION AND CRYSTAL STRUCTURE
2ZLCA:123-4202-SUBSTITUTED-16-ENE-22-THIA-1ALPHA,25-DIHYDROXY-26,27-DIMETHYL-19-NORVITAMIN D3 ANALOGS: SYNTHESIS, BIOLOGICAL EVALUATION AND CRYSTAL STRUCTURE
2ZMHA:123-420CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM
2ZMIA:121-420CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM
2ZMJA:123-420CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM
3G0WA:670-918CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN COMPLEX WITH AN N-ARYL-OXAZOLIDIN 2-IMINE INHIBITOR
(-)
Red flour beetle (Tribolium castaneum) (1)
2NXXB:178-405; D:180-406; C:180-404; A:180-403; E:311-547; H:311-547; F:311-546; G:311-546CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A
(-)
Tobacco budworm (Heliothis virescens) (4)
1G2NA:203-458CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE ULTRASPIRACLE PROTEIN USP, THE ORTHOLOG OF RXRS IN INSECTS
1R1KA:205-455; D:287-529CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO PONASTERONE A
1R20A:206-455; D:287-528CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO THE SYNTHETIC AGONIST BYI06830
2R40A:206-455; D:287-529CRYSTAL STRUCTURE OF 20E BOUND ECR/USP
(-)
Unidentified. Organism_taxid: 32644. (3)
2Q1HA:0-246ANCESTRAL CORTICOID RECEPTOR IN COMPLEX WITH ALDOSTERONE
2Q1VA:0-246ANCESTRAL CORTICOID RECEPTOR IN COMPLEX WITH CORTISOL
2Q3YA:0-246ANCESTRAL CORTICIOD RECEPTOR IN COMPLEX WITH DOC
(-)
Zebrafish (Danio rerio) (3)
2HBHA:154-452CRYSTAL STRUCTURE OF VITAMIN D NUCLEAR RECEPTOR LIGAND BINDING DOMAIN BOUND TO A LOCKED SIDE-CHAIN ANALOG OF CALCITRIOL AND SRC-1 PEPTIDE
2HC4A:154-452CRYSTAL STRUCTURE OF THE LBD OF VDR OF DANIO RERIO IN COMPLEX WITH CALCITRIOL
2HCDA:154-452CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE VITAMIN D NUCLEAR RECEPTOR IN COMPLEX WITH GEMINI AND A COACTIVATOR PEPTIDE